Intimate partner violence and suicidal ideation in pregnant women.

Intimate partner violence and suicidal ideation in pregnant women.
复制标题

DOI:
10.1007/s00737-015-0515-2
复制
发表时间:
2015-08
期刊:
Archives of women's mental health
影响因子:
--
通讯作者:
Purcell G
Purcell G
中科院分区:
其他
文献类型:
--
作者:
Alhusen JL;Frohman N;Purcell G

文献摘要

被引文献

相似文献

孕期亲密伴侣暴力(IPV)是一个重大的公共卫生问题,对产妇的心理健康有重大影响。怀孕期间的IPV与自杀意念之间的联系研究较少。本研究报告了2009年2月至2010年3月在一所大学产科诊所接受产前护理的低收入孕妇中自杀意念的患病率及其相关性。我们使用爱丁堡产后抑郁量表(EPDS)和虐待评估筛查(AAS)对166名怀孕24-28周的妇女进行了横断面分析。多因素Logistic回归确定了与产前自杀意念相关的因素。自杀意念发生率为22.89%。在完全调整的模型中,产前抑郁症状(OR=17.04;95%CI 2.10~38.27)和经历IPV(OR=9.37;95%CI 3.41~25.75)与产前自杀意念的风险增加显著相关。在目前的研究中,产前自杀意念的流行率高于其他基于人群的样本,尽管该样本主要是单身、低收入,19%的人在怀孕期间经历过IPV。鉴于产前自杀意念、抑郁症状和IPV之间的强烈关联,敦促卫生保健提供者识别那些有风险的妇女,以便为产前护理量身定做,以最大限度地支持最佳的孕产妇和新生儿结局。
Intimate partner violence (IPV) during pregnancy is a major public health issue with significant implications for maternal mental health. Less studied is the association between IPV during pregnancy and suicidal ideation. This study reports the prevalence and correlates of suicidal ideation among low-income pregnant women receiving prenatal care at a university obstetrical clinic from February 2009 to March 2010. We performed a cross-sectional analysis of 166 women surveyed between 24 – 28 weeks gestation using the Edinburgh Postnatal Depression Scale (EPDS) and the Abuse Assessment Screen (AAS). Multiple logistic regression identified factors associated with antenatal suicidal ideation. The prevalence of suicidal ideation was 22.89%. In the fully adjusted model antenatal depressive symptomatology (OR = 17.04; 95% CI 2.10 – 38.27) and experiencing IPV (OR = 9.37; 95% CI 3.41 – 25.75) were significantly associated with an increased risk of antenatal suicidal ideation. The prevalence of antenatal suicidal ideation in the current study was higher than other population-based samples though this sample was predominantly single, low-income, and 19% experienced IPV during pregnancy. Given the strong association of antenatal suicidal ideation, depressive symptomatology, and IPV, health care providers are urged to identify those women at risk so that antenatal care can be tailored to best support optimal maternal and neonatal outcomes.